Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

NCT00002892 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant interferon alfa

Sponsor

Institute of Cancer Research, United Kingdom